Ryan Potter

Ryan Potter

Auto-generated profile, based on publicly available information

Ryan Potter

Department of Genetics, CHEO, Ottawa, Ontario, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
HDHussein Daoud
Hussein Daoud
MGMahdi Ghani
Mahdi Ghani
LNLandry Nfonsam
Landry Nfonsam
RPRyan Potter
Ryan Potter
SOShelley Ordorica
Shelley Ordorica
OJOlga Jarinova
Olga Jarinova

21 September 2018 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
LNLandry Nfonsam
Landry Nfonsam
SOShelley Ordorica
Shelley Ordorica
MGMahdi Ghani
Mahdi Ghani
RPRyan Potter
Ryan Potter
ASAudrey Schaffer
Audrey Schaffer
LBLucas Bronicki
Lucas Bronicki
Background: Advances in molecular technologies and in-silico variant prediction tools offer wide-ranging opportunities in diagnostic settings, yet they also present with significant limitations. Objective: Here, we contextualise the limitations of next-generation sequencing (NGS), multiplex ligation-dependent probe amplification (MLPA) and in-silico prediction tools routinely used by diagnostic laboratories by reviewing specific experiences from our diagnostic laboratory. Methods: We investigated discordant annotations and/or incorrect variant ‘callings’ in exons of 56 genes constituting our cardiomyopathy and connective tissue disorder NGS panels. Discordant variants and segmental duplications (SD) were queried using the National Center for Biotechnology Information (NCBI) Basic Local Alignment Search Tool and the University of California Santa Cruz genome browser, respectively, to identify regions of high homology. Discrepant variant analyses by in-silico models were re-evaluated using updated file entries. Results: We observed a 5% error rate in MYH7 variant ‘calling’ using MLPA, which resulted from >90% homology of the MYH7 probe-binding site to MYH6. SDs were detected in TTN, PKP2 and MYLK. SDs in MYLK presented the highest risk (15.7%) of incorrect variant ‘calling’. The inaccurate ‘callings’ and discrepant in-silico predictions were resolved following detailed investigation into the source of error. Conclusion: Recognising the limitations described here may help avoid incorrect diagnoses and leverage the power of new molecular technologies in diagnostic settings.

1 July 2019 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
MGMahdi Ghani
Mahdi Ghani
LNLandry Nfonsam
Landry Nfonsam
EPErinija Pranckeviciene
Erinija Pranckeviciene
HDHussein Daoud
Hussein Daoud
RPRyan Potter
Ryan Potter
OJOlga Jarinova
Olga Jarinova